197 related articles for article (PubMed ID: 32631576)
1. Carvedilol and COVID-19: A Potential Role in Reducing Infectivity and Infection Severity of SARS-CoV-2.
Skayem C; Ayoub N
Am J Med Sci; 2020 Sep; 360(3):300. PubMed ID: 32631576
[No Abstract] [Full Text] [Related]
2. Covid-19: the renin-angiotensin system imbalance hypothesis.
Lanza K; Perez LG; Costa LB; Cordeiro TM; Palmeira VA; Ribeiro VT; Simões E Silva AC
Clin Sci (Lond); 2020 Jun; 134(11):1259-1264. PubMed ID: 32507883
[TBL] [Abstract][Full Text] [Related]
3. SARS-CoV-2 & Covid-19: Key-Roles of the 'Renin-Angiotensin' System / Vitamin D Impacting Drug and Vaccine Developments.
Cao Z; Wu Y; Faucon E; Sabatier JM
Infect Disord Drug Targets; 2020; 20(3):348-349. PubMed ID: 32370727
[No Abstract] [Full Text] [Related]
4. Renin-Angiotensin-Aldosterone System Inhibitors in Patients with Covid-19.
Vaduganathan M; Vardeny O; Michel T; McMurray JJV; Pfeffer MA; Solomon SD
N Engl J Med; 2020 Apr; 382(17):1653-1659. PubMed ID: 32227760
[No Abstract] [Full Text] [Related]
5. Estrogen regulates the expression of SARS-CoV-2 receptor ACE2 in differentiated airway epithelial cells.
Stelzig KE; Canepa-Escaro F; Schiliro M; Berdnikovs S; Prakash YS; Chiarella SE
Am J Physiol Lung Cell Mol Physiol; 2020 Jun; 318(6):L1280-L1281. PubMed ID: 32432918
[TBL] [Abstract][Full Text] [Related]
6. Recombinant human ACE2: potential therapeutics of SARS-CoV-2 infection and its complication.
Pang X; Cui Y; Zhu Y
Acta Pharmacol Sin; 2020 Sep; 41(9):1255-1257. PubMed ID: 32581256
[No Abstract] [Full Text] [Related]
7. The interplay of hypertension, ACE-2 and SARS-CoV-2: Emerging data as the "Ariadne's thread" for the "labyrinth" of COVID-19.
Tsioufis C; Dimitriadis K; Tousoulis D
Hellenic J Cardiol; 2020; 61(1):31-33. PubMed ID: 32450334
[No Abstract] [Full Text] [Related]
8. Sitagliptin Repositioning in SARS-CoV-2: Effects on ACE-2, CD-26, and Inflammatory Cytokine Storms in the Lung.
Dastan F; Abedini A; Shahabi S; Kiani A; Saffaei A; Zare A
Iran J Allergy Asthma Immunol; 2020 May; 19(S1):10-12. PubMed ID: 32534505
[TBL] [Abstract][Full Text] [Related]
9. COVID-19 and cardiovascular disease: What we know, what we think we know, and what we need to know.
Dhawan R; Gundry RL; Brett-Major DM; Mahr C; Thiele GM; Lindsey ML; Anderson DR
J Mol Cell Cardiol; 2020 Jul; 144():12-14. PubMed ID: 32339565
[No Abstract] [Full Text] [Related]
10. Angiotensin II suppression in SARS-CoV-2 infection: a therapeutic approach.
Lamas-Barreiro JM; Alonso-Suárez M; Fernández-Martín JJ; Saavedra-Alonso JA
Nefrologia (Engl Ed); 2020; 40(3):213-216. PubMed ID: 32456945
[No Abstract] [Full Text] [Related]
11. Does SARS-CoV-2 infection cause sperm DNA fragmentation? Possible link with oxidative stress.
Sengupta P; Dutta S
Eur J Contracept Reprod Health Care; 2020 Oct; 25(5):405-406. PubMed ID: 32643968
[No Abstract] [Full Text] [Related]
12. COVID-19 and renin-angiotensin system inhibition: role of angiotensin converting enzyme 2 (ACE2) - Is there any scientific evidence for controversy?
Aleksova A; Ferro F; Gagno G; Cappelletto C; Santon D; Rossi M; Ippolito G; Zumla A; Beltrami AP; Sinagra G
J Intern Med; 2020 Oct; 288(4):410-421. PubMed ID: 32459372
[TBL] [Abstract][Full Text] [Related]
13. Clinical analysis of sinus bradycardia in patients with severe COVID-19 pneumonia.
Hu L; Gong L; Jiang Z; Wang Q; Zou Y; Zhu L
Crit Care; 2020 May; 24(1):257. PubMed ID: 32456695
[No Abstract] [Full Text] [Related]
14. Correlation between renin-angiotensin system and Severe Acute Respiratory Syndrome Coronavirus 2 infection: What do we know?
Vitiello A; Ferrara F
Eur J Pharmacol; 2020 Sep; 883():173373. PubMed ID: 32679185
[TBL] [Abstract][Full Text] [Related]
15. COVID-19 and obesity: links and risks.
Lavie CJ; Sanchis-Gomar F; Henry BM; Lippi G
Expert Rev Endocrinol Metab; 2020 Jul; 15(4):215-216. PubMed ID: 32441223
[No Abstract] [Full Text] [Related]
16. Impaired Breakdown of Bradykinin and Its Metabolites as a Possible Cause for Pulmonary Edema in COVID-19 Infection.
de Maat S; de Mast Q; Danser AHJ; van de Veerdonk FL; Maas C
Semin Thromb Hemost; 2020 Oct; 46(7):835-837. PubMed ID: 32526773
[No Abstract] [Full Text] [Related]
17. ACEI/ARB therapy in COVID-19: the double-edged sword of ACE2 and SARS-CoV-2 viral docking.
Onweni CL; Zhang YS; Caulfield T; Hopkins CE; Fairweather L; Freeman WD
Crit Care; 2020 Jul; 24(1):475. PubMed ID: 32736573
[No Abstract] [Full Text] [Related]
18. ACE2 receptor expression in testes: implications in coronavirus disease 2019 pathogenesis†.
Verma S; Saksena S; Sadri-Ardekani H
Biol Reprod; 2020 Aug; 103(3):449-451. PubMed ID: 32427288
[TBL] [Abstract][Full Text] [Related]
19. COVID-19 and Kidney Disease: Molecular Determinants and Clinical Implications in Renal Cancer.
Mihalopoulos M; Dogra N; Mohamed N; Badani K; Kyprianou N
Eur Urol Focus; 2020 Sep; 6(5):1086-1096. PubMed ID: 32540268
[TBL] [Abstract][Full Text] [Related]
20. The role of ACEIs/ARBs in COVID-19: Friend or foe?
Zhou Z; Qiu Y; Tao J
Med Hypotheses; 2020 Sep; 142():109810. PubMed ID: 32413701
[No Abstract] [Full Text] [Related]
[Next] [New Search]
